EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors

Zhaoquan Wu, Rui Huang, Wei Sun, Binsheng He, Chunjiang Wang

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03484-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Zhaoquan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Changsha Medical University, No. 1501 Leifeng Avenue, Xiangjiang New District, Changsha, Hunan, 410219, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Cutaneous, Immune Checkpoint Inhibitors, Antibodies, Monoclonal, Humanized, Nivolumab. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Hunan Provincial Key Laboratory of the Traditional Chinese Medicine Agricultural Biogenomics and.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, CutaneousImmune Checkpoint InhibitorsAntibodies, Monoclonal, HumanizedNivolumabB7-H1 AntigenProgrammed Cell Death 1 ReceptorHumansFemaleMiddle AgedMaleAgedAdultAged, 80 and overRetrospective StudiesTreatment OutcomeAntibodies, AntinuclearSkinHydroxychloroquineBiopsy

Stichwörter der Autor:innen

Drug reactionImmune-related adverse eventsPD-1 inhibitorSubacute cutaneous lupus erythematosus

Substanzen

Immune Checkpoint InhibitorspembrolizumabAntibodies, Monoclonal, HumanizedNivolumabPDCD1 protein, humanB7-H1 AntigenCD274 protein, humanProgrammed Cell Death 1 ReceptorAntibodies, AntinuclearHydroxychloroquine

Autor:innen und Institutionen

  • College of Pharmacy, Changsha Medical University, No. 1501 Leifeng Avenue, Xiangjiang New District, Changsha, Hunan, 410219, China.
  • Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, Hunan, 410219, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
  • Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
  • College of Pharmacy, Changsha Medical University, No. 1501 Leifeng Avenue, Xiangjiang New District, Changsha, Hunan, 410219, China. wongcj@csu.edu.cn.
  • Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, Hunan, 410219, China. wongcj@csu.edu.cn.

Förderung

  • Natural Science Foundation of Hunan Province
  • Hunan Provincial Key Laboratory of the Traditional Chinese Medicine Agricultural Biogenomics and

Zitieren

APA

Wu, Z., Huang, R., Sun, W., He, B., & Wang, C. (2024). Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03484-1

Vancouver

Wu Z, Huang R, Sun W, He B, Wang C. Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03484-1

BibTeX
@article{Wu2024,
  author = {Wu, Zhaoquan and Huang, Rui and Sun, Wei and He, Binsheng and Wang, Chunjiang},
  title = {Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03484-1}
}
Kostenlos starten →